
To domestic manufacturing of bulk drug, the government Saturday announced a Rs 14,000 crore package that would incentivise production of active pharmaceutical ingredient (API) in the country and reduce import dependence of this key pharma input from China.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3dkl3s0
via
IFTTT
0 comments:
Post a Comment